Canaccord Genuity Maintains Buy on Core Scientific, Maintains $17 Price Target

Benzinga · 05/09 10:39
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and maintains $17 price target.